Skip to content

Effects of a pain consult and patient education and monitoring: a prospective study in oncology patients.

Effects of a pain consult and patient education and monitoring: a prospective study in oncology patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON23628
Enrollment
165
Registered
2006-02-22
Start date
2006-02-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

1. Second opinion pain consult at the specialist pain clinic
2. Second opinion pain consult combined with Pain Education Program and monitoring by nurse specialists.

Sponsors

Erasmus MC the Netherlands
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Cancer-related pain or cancer treatment related pain for at least two weeks; 2. Nociceptive pain; 3. Average pain intensity score of 4 or more; 4. Accessibility by telephone; 5. A life expectancy of at least three months; 6. Informed consent.

Exclusion criteria

Exclusion criteria: 1. Neuropathic pain; 2. Residing in nusing home or retirement home; 3. Pain not treated with oral medication; 4. Radiotherapy in the past two weeks.

Design outcomes

Primary

MeasureTime frame
Average pain reduction measured by numeric rating scale during the study period.

Secondary

MeasureTime frame
Effect of the interventions after 2, 4 and 8 weeks at: 1. Adherence to ATC analgesics; 2. Worst pain reduction; 3. Average pain reduction; 4. Present pain reduction; 5. Proportion of patients with clinically relevant pain reduction; 6. Pain interference; 7. Quality of life; 8. Reduction of side effects; 9. Adequacy of pain treatment; 10. Pain knowledge.

Contacts

Public ContactW.H. Oldenmenger

Erasmus Medical Center, Daniel den Hoed Cancer Center, P.O. Box 5201

w.h.oldenmenger@erasmusmc.nl+31 (0)10 4391439

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)